Saturday 17 October 2026
Export AHI’s income statement to Excel — free account
Advanced Human Imaging Limited Sponsored ADR
AHI Technology Software Application
Advanced Human Imaging Limited Sponsored ADR’s revenue for fiscal 2023 (year ended June 2023) was $1.9 million, up 484.3% from fiscal 2022. Revenue growth for three consecutive years, operating cash flow growth for three.
1.50
0.00
0.00%
Follow AHI
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 4 | 3 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 519.26 | 519.26 | 519.26 | 519.26 | 66.00 | 112.47 |
Altman Z-Score |
— | — | — | — | — | (9.12) | (13.29) |
Altman Z″-Score (non-manufacturers) |
— | (131.05) | (60.95) | (46.48) | (42.37) | (25.06) | (38.80) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | (11.03) | (8.17) | (1.44) |
P/Operating CF |
— | (230.31) | (230.31) | (230.31) | (230.31) | (31.58) | (52.13) |
P/B ratio |
— | 145.13 | 145.13 | 145.13 | 145.13 | 6.34 | 47.60 |
Price to Tangible BV |
— | 376.72 | 376.72 | 376.72 | 376.72 | 7.16 | 0.00 |
EV/Sales |
— | 519.37 | 519.37 | 519.37 | 519.37 | 60.12 | 112.04 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (32.09) | (32.09) | (32.09) | (32.09) | (2.44) | (3.70) |
EV/FCF |
— | (32.09) | (32.09) | (32.09) | (32.09) | (2.41) | (3.66) |
Quick Ratio |
3.01 | 0.37 | 0.29 | 0.45 | 0.71 | 2.96 | 0.40 |
Current Ratio |
3.17 | 0.45 | 0.29 | 0.60 | 1.18 | 3.40 | 0.54 |
Net Debt/EBITDA |
0.39 | (0.02) | (0.17) | (0.12) | 0.00 | 0.24 | 0.03 |
Debt/Assets |
0.00% | 23.91% | 56.90% | 44.86% | 41.12% | 10.41% | 19.52% |
Debt/Equity |
0.00 | 0.69 | 2.73 | 2.87 | 1.13 | 0.13 | 0.86 |
Asset Turnover |
0.00 | 1.60 | 0.00 | 0.28 | 0.29 | 0.05 | 0.27 |
Operating CF/Net income |
0.83 | 0.09 | 0.75 | 0.50 | 0.29 | 0.49 | 0.57 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.25) | (0.07) | (0.24) | (0.18) |
Interest Coverage |
(117.87) | (2,443.89) | (82.61) | (41.22) | (58.38) | (127.88) | (26.38) |
| (138.90%) | (850.28%) | (677.61%) | (1,275.35%) | (1,152.26%) | (355.91%) | (228.08%) | |
| (90.94%) | (1,384.20%) | (183.02%) | (225.12%) | (335.76%) | (221.40%) | (125.76%) | |
ROIC |
0.00% | 0.00% | 0.00% | (318.73%) | (449.56%) | (358.47%) | (474.08%) |
Return on Tangible Assets |
(245.36%) | 3,305.51% | 306.41% | 736.72% | (2,097.72%) | (400.91%) | 488.89% |
Average Days of Receivables |
0.00 | 30.69 | 2,015.43 | 160.89 | 73.86 | 42.12 | 40.80 |
Research and Development Expense of Revenue |
— | 1.94% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 1,015.62% | 118,504.35% | 987.16% | 1,083.47% | 4,485.41% | 357.60% |
Intangible Assets out of Total Assets |
0.00 | 0.78 | 0.55 | 0.46 | 0.22 | 0.09 | 0.48 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 310.82% | 606.84% | 1,681.74% | 3.76% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | (0.04) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (0.74%) | (0.74%) | (0.74%) | (0.74%) | (8.54%) | (3.84%) |
Free Cash Flow Yield |
— | (3.12%) | (3.12%) | (3.12%) | (3.12%) | (37.81%) | (27.21%) |
Revenue per Share |
0.00 | 0.10 | 0.00 | 0.18 | 0.27 | 0.06 | 0.28 |
Operating CF per Share |
(0.11) | (0.08) | (0.64) | (0.72) | (0.92) | (1.30) | (0.75) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.02) | (0.01) | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.11) | (0.08) | (0.64) | (0.74) | (0.92) | (1.32) | (0.76) |
Cash per Share |
0.07 | 0.01 | 0.11 | 0.17 | 0.48 | 0.80 | 0.21 |
Shareholders Equity per Share |
0.14 | 0.04 | 0.11 | 0.12 | 0.44 | 1.13 | 0.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.14 | 0.04 | 0.11 | 0.12 | 0.44 | 1.13 | 0.21 |
Free Cash Flow |
(1.40) | (0.95) | (2.28) | (2.76) | (4.13) | (7.22) | (5.00) |
Working Capital |
0.66 | (0.34) | (1.03) | (0.81) | 0.61 | 3.56 | (1.87) |
Capital Expenditures |
(0.54) | (0.15) | (0.06) | (0.06) | (0.02) | (0.06) | (0.05) |
Net Current Asset Value |
0.66 | (0.70) | (1.03) | (1.27) | 0.56 | 3.52 | (2.44) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.09 | 0.02 | 0.19 | 0.02 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
0.41 | 4.67 | 3.56 | 3.14 | 5.96 | 3.84 | 2.43 |
Cash ROIC |
(49.82%) | (95.37%) | (124.39%) | (114.26%) | (64.67%) | (63.44%) | (126.64%) |
Accounts Receivable Turnover |
0.00 | 19.13 | 0.05 | 4.28 | 4.47 | 2.29 | 15.20 |
Accounts Payable Turnover |
0.15 | 1.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
1.46 | 18.86 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
1,730.47 | 254.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
378.13 | 9.40 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.06 | 0.06 | 0.06 | 0.16 | 0.27 | 0.14 | 0.12 |
Average Payables |
0.07 | 0.07 | 0.08 | 0.43 | 0.67 | 0.46 | 1.35 |
Average Inventory |
0.01 | 0.01 | 0.00 | 0.00 | — | — | — |
Average Assets |
1.85 | 0.74 | 1.66 | 2.40 | 4.19 | 6.58 | 6.87 |
Average Common Equity |
1.21 | 1.21 | 0.45 | 0.42 | 1.22 | 4.09 | 3.79 |
Columns are period end dates